
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 134
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 134
Showing 1-25 of 134 citing articles:
Outcomes of laboratory‐confirmed SARS‐CoV ‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary‐Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
Tropical Medicine & International Health (2022) Vol. 27, Iss. 6, pp. 564-573
Open Access | Times Cited: 118
Mary‐Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
Tropical Medicine & International Health (2022) Vol. 27, Iss. 6, pp. 564-573
Open Access | Times Cited: 118
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou Zhou, Yimiao Zhu, Ming Chu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Zhou Zhou, Yimiao Zhu, Ming Chu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Severity of the Omicron SARS‐CoV ‐2 variant compared with the previous lineages: A systematic review
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 51
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 51
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
Lindsey Wang, David C. Kaelber, Rong Xu, et al.
Blood Reviews (2022) Vol. 54, pp. 100931-100931
Open Access | Times Cited: 64
Lindsey Wang, David C. Kaelber, Rong Xu, et al.
Blood Reviews (2022) Vol. 54, pp. 100931-100931
Open Access | Times Cited: 64
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 63
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 63
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary‐Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 61
Mary‐Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 61
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study
Jacek Skarbinski, Mariah S. Wood, Tyler C. Chervo, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100297-100297
Open Access | Times Cited: 57
Jacek Skarbinski, Mariah S. Wood, Tyler C. Chervo, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100297-100297
Open Access | Times Cited: 57
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections
Winnie W. Y. Tso, Mike Yat Wah Kwan, Yu Liang Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1742-1750
Open Access | Times Cited: 56
Winnie W. Y. Tso, Mike Yat Wah Kwan, Yu Liang Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1742-1750
Open Access | Times Cited: 56
COVID-19 Pathogenesis and Clinical Manifestations
R Alfonso Hernandez Acosta, Zerelda Esquer Garrigos, Jasmine R Marcelin, et al.
Infectious Disease Clinics of North America (2022) Vol. 36, Iss. 2, pp. 231-249
Open Access | Times Cited: 51
R Alfonso Hernandez Acosta, Zerelda Esquer Garrigos, Jasmine R Marcelin, et al.
Infectious Disease Clinics of North America (2022) Vol. 36, Iss. 2, pp. 231-249
Open Access | Times Cited: 51
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines
Violette Mouro, Alain Fischer
Mucosal Immunology (2022) Vol. 15, Iss. 4, pp. 584-594
Open Access | Times Cited: 51
Violette Mouro, Alain Fischer
Mucosal Immunology (2022) Vol. 15, Iss. 4, pp. 584-594
Open Access | Times Cited: 51
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 5, pp. e347-e355
Open Access | Times Cited: 46
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 5, pp. e347-e355
Open Access | Times Cited: 46
Recent insights into SARS‐CoV‐2 omicron variant
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 43
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 43
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review
Aparajita Sarkar, Sara Omar, Aya Alshareef, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Aparajita Sarkar, Sara Omar, Aya Alshareef, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 24
The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children
Djatnika Setiabudi, Yunia Sribudiani, Kartika Hermawan, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 33
Djatnika Setiabudi, Yunia Sribudiani, Kartika Hermawan, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 33
COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles
Alberto Corriero, Mario Ribezzi, Federica Mele, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 3, pp. 492-500
Open Access | Times Cited: 30
Alberto Corriero, Mario Ribezzi, Federica Mele, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 3, pp. 492-500
Open Access | Times Cited: 30
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV ‐2 variants
Kameran M. Ali, Peshnyar M.A. Rashid, Ayad M. Ali, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 9
Open Access | Times Cited: 19
Kameran M. Ali, Peshnyar M.A. Rashid, Ayad M. Ali, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 9
Open Access | Times Cited: 19
Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination
Elena Varea-Jiménez, Esteban Aznar Cano, Lorena Vega‐Piris, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2023) Vol. 42, Iss. 4, pp. 187-194
Open Access | Times Cited: 15
Elena Varea-Jiménez, Esteban Aznar Cano, Lorena Vega‐Piris, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2023) Vol. 42, Iss. 4, pp. 187-194
Open Access | Times Cited: 15